84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2013-000242-18-NL (EUCTR) | 23/05/2013 | 11/04/2013 | Low dose dexamethasone in newly diagnosed sarcoidosis | Low dose dexamethasone in newly diagnosed sarcoidosis - (DEXSAR) Trial | Patients with newly diagnosed, pulmonary sarcoidosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Trade Name: Dexamethasone 0,5mg Product Name: Dexamethasone INN or Proposed INN: DEXAMETHASONE Other descriptive name: Dexamethasone | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands |